0       0

NACCT 2017


WED1245a - ACMT Pre-Symposium: Up for Debate: Addressing Controversies in Poisoning


Oct 11, 2017 12:45pm ‐ Oct 11, 2017 5:30pm


Credits: None available.

Description

Bryan Judge, MD, FAAEM, FACMT 
In the News: How lead in Flint, MI, Opened the Public's Eyes
Learning Objective:

  1. Discuss the water crisis in Flint, Michigan

Cynthia Aaron, MD
In the News: How lead in Flint, MI, Opened the Public's Eyes
Learning Objective:

  1. Discuss the water crisis in Flint, Michigan

William Banner, MD, PhD
Lead in the Water: Drink Up?
Learning Objectives:

  1. Understand the basis for concerns regarding low level exposure to lead
  2. Recognize the limited contribution of lead in drinking water to blood lead

Michael Kosnett, MD, MPH
Lead in the Water: Don't Swallow!
Learning Objectives:

  1. Understand the cost benefit value of lead poisoning prevention
  2. Recognize the strength of causal evidence linking low level lead exposure to adverse cognitive effects in children

Alison Jones, MD
Nar-CAN Go: Fast and Furious
Learning Objective:

  1. Understand clinical indications for consideration of higher doses of naloxone

Rob Hendricksen, MD, PhD
Low Dose Naloxone: Slow and Steady Wins the Race
Learning Objective:

  1. Minimize naloxone-associated side effects while treating opioid overdoses 

Christina Hantsch, MD
CNS Depression Re-Versed
Learning Objective:

  1. Identify clinical situations in which use of flumazenil is likely to be beneficial

Marco Sivilotti, MD
Flumaz-evil: Keep it out of My Coma Cocktail
Learning Objectives:

  1. Justify the avoidance of the routine use of flumazenil for CNS depression following overdose
  2. Discuss potential adverse effects of flumazenil use

Spencer Greene, MD
The Best Part of Waking Up (An Antimuscarinic Patient) is With Physostigmine in Your Cup
Learning Objectives:

  1. Identify the situations where physostigmine is indicated
  2. Recognize legitimate contraindications to the use of physostigmine

Brenna Farmer, MD
Anti Antillirium
Learning Objective:

  1. Discuss when physostigmine should not be used

Speaker(s):

Speaker(s):

Credits

Credits: None available.

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content